◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

NEUROCRINE BIOSCIENCES INC

CIK: 914475 SIC: 2836
$2.86B
Revenue
$478.60M
Net Income
98.18%
Gross Margin
21.64%
Op. Margin
$946.40M
Free Cash Flow
Financial Statements Annual (10-K)
Showing 5 of 15 annual reports available (2011 - 2025)
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
+ Total Revenue $2.86B $2.86B $2.36B $1.89B $1.49B $1.13B
Revenue Growth % 0.0% 21.4% 24.8% 26.8% 31.3% nan%
Cost of Revenue $52.10M $52.10M $34.00M $39.70M $23.20M $14.30M
+ Gross Profit $2.81B $2.81B $2.32B $1.85B $1.47B $1.12B
Gross Margin % 98.2% 98.2% 98.6% 97.9% 98.4% 98.7%
Operating Expenses $2.24B $2.24B $1.78B $1.64B $1.24B $1.03B
Selling General & Admin $1.16B $1.16B $1.01B $887.60M $752.70M $583.30M
+ Operating Income $619.10M $619.10M $570.50M $250.90M $249.00M $102.50M
Operating Margin % 21.6% 21.6% 24.2% 13.3% 16.7% 9.0%
Interest Expense - - $1.60M $4.60M $7.10M $25.80M
Other Income/Expense $86.30M $86.30M $-84.50M $81.20M $-35.10M $-1.10M
Income Before Tax $705.40M $705.40M $486.00M $332.10M $213.90M $101.40M
Income Tax Expense $226.80M $226.80M $144.70M $82.40M $59.40M $11.80M
+ Net Income $478.60M $478.60M $341.30M $249.70M $154.50M $89.60M
Net Margin % 16.7% 16.7% 14.5% 13.2% 10.4% 7.9%
Basic EPS 4.82 4.81 3.40 2.56 1.61 0.95
Diluted EPS 4.66 4.67 3.29 2.47 1.56 0.92
Basic Shares Outstanding - 99.5M 100.4M 97.7M 95.8M 94.6M
Diluted Shares Outstanding - 102.5M 103.7M 101.0M 98.9M 97.9M
Breakdown FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
Cash & Cash Equivalents $713.00M $233.00M $251.10M $262.90M $340.80M
Short-term Investments - - - - $370.50M
Accounts Receivable $686.80M $479.10M $439.30M $350.00M $185.50M
Inventory $69.00M $57.40M $38.30M $35.10M $30.50M
Other Current Assets $115.80M $112.10M $97.80M $79.10M $45.50M
Total Current Assets $2.52B $1.72B $1.61B $1.45B $972.80M
Property Plant & Equipment $89.80M $82.60M $70.80M $58.60M $58.60M
Intangible Assets - $36.50M $35.50M $37.20M -
Long-term Investments - - - $299.40M $560.70M
Other Non-current Assets $59.50M $15.50M $49.60M $25.00M $4.40M
Total Assets $4.63B $3.72B $3.25B $2.37B $2.07B
Other Current Liabilities $69.10M $46.10M $35.90M $20.70M $20.00M
Total Current Liabilities $743.40M $507.70M $654.80M $537.70M $245.80M
Other Non-current Liabilities $219.70M $166.20M $106.30M $29.70M $12.30M
Total Liabilities $1.38B $1.13B $1.02B $660.90M $698.50M
Common Stock $100.00K $100.00K $100.00K $100.00K $100.00K
Retained Earnings $447.70M $29.20M $-157.10M $-406.80M $-635.80M
Total Stockholders Equity $3.25B $2.59B $2.23B $1.71B $1.37B
Total Liabilities & Equity $4.63B $3.72B $3.25B $2.37B $2.07B
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
Net Income $478.60M $478.60M $341.30M $249.70M $154.50M $89.60M
Stock-based Compensation $376.30M $217.90M $195.50M $194.30M $173.10M $134.20M
Deferred Income Tax - $164.20M $-123.00M $-60.70M - -
Change in Receivables $364.00M $210.50M $39.80M $89.30M $162.20M $28.40M
Change in Inventory $16.60M $15.30M $19.10M $-5.40M $2.60M $2.50M
Operating Cash Flow $1.01B $782.70M $595.40M $389.90M $339.40M $256.50M
Capital Expenditure $67.90M $34.00M $38.20M $28.30M $16.50M $23.40M
Acquisitions - - - - $42.70M -
Investing Cash Flow $-265.00M $-264.40M $-126.80M $-467.10M $-177.10M $-130.20M
Stock Issued $208.00M $129.40M $122.10M $65.30M $44.70M $27.50M
Stock Repurchased $485.40M $167.70M $300.00M - - -
Financing Cash Flow $-277.40M $-38.30M $-486.70M $65.30M $-234.30M $27.40M
Net Change in Cash $472.10M $480.00M $-18.10M $-11.60M $-73.30M $153.70M
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Total Revenue $794.90M - $2.06B -
Cost of Revenue $14.00M - $34.50M -
Operating Expenses $555.90M - $1.65B -
Selling General & Admin $291.60M - $854.40M -
Operating Income $239.00M - $408.20M -
Interest Expense - - - -
Other Income/Expense $52.80M - $57.80M -
Income Before Tax $291.80M - $466.00M -
Income Tax Expense $82.30M - $141.10M -
Net Income $209.50M - $324.90M -
Basic EPS 2.11 - 3.27 -
Diluted EPS 2.04 - 3.19 -
Basic Shares Outstanding $99.40M - $99.30M -
Diluted Shares Outstanding $102.50M - $102.00M -
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $340.20M $233.00M
Accounts Receivable $728.00M $479.10M
Inventory $69.30M $57.40M
Other Current Assets $68.20M $63.60M
Total Current Assets $2.16B $1.72B
Property Plant & Equipment $97.30M $82.60M
Intangible Assets $35.70M $36.50M
Other Non-current Assets $20.30M $15.50M
Total Assets $4.27B $3.72B
Other Current Liabilities $53.70M $46.10M
Total Current Liabilities $638.00M $507.70M
Other Non-current Liabilities $195.70M $166.20M
Total Liabilities $1.26B $1.13B
Common Stock $100.00K $100.00K
Retained Earnings $294.00M $29.20M
Total Stockholders Equity $3.00B $2.59B
Total Liabilities & Equity $4.27B $3.72B
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $209.50M - $324.90M -
Stock-based Compensation - - $159.30M -
Change in Receivables - - $248.90M -
Change in Inventory - - $11.90M -
Operating Cash Flow - - $394.30M -
Capital Expenditure - - $36.40M -
Investing Cash Flow - - $-211.50M -
Stock Issued - - $92.10M -
Stock Repurchased - - $167.70M -
Financing Cash Flow - - $-75.60M -
Net Change in Cash - - $107.20M -

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.

Annual data represents full fiscal year results. FY = Fiscal Year ending.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...